Iridex Partners with EyeProGPO to Expand Access to Retina Laser Tech

The deal will provide EyeProGPO's 1,800+ members preferred pricing on Iridex's retina laser devices.

Apr. 7, 2026 at 8:35pm

Got story updates? Submit your updates here. ›

A minimalist, high-contrast studio photograph of a sleek, geometric laser device made of brushed metal and glass, floating on a clean white background and dramatically lit to showcase its precision and advanced capabilities.Iridex's retina laser devices, now available to EyeProGPO members at preferred pricing, represent the latest advancements in ophthalmic technology.Mountain View Today

Iridex Corporation, a leader in laser-based medical systems for ophthalmology, has announced a new partnership with EyeProGPO, an ophthalmology group purchasing organization. Through the deal, EyeProGPO's 1,800+ member practices, surgery centers, and hospitals will receive preferred pricing on Iridex's retina laser platforms, including the PASCAL, IQ 532, IQ 577, and OcuLight TX models. The partnership aims to improve access to Iridex's proven retina laser technology and support value-based purchasing decisions for EyeProGPO members.

Why it matters

The partnership reflects Iridex's commitment to supporting ophthalmology providers with reliable, clinically proven laser solutions while helping them achieve operational efficiency and cost savings. It also aligns with EyeProGPO's goal of equipping its members with the latest advancements in eye care technology to deliver high-quality patient care.

The details

Under the new agreement, EyeProGPO members will receive preferred pricing on Iridex's retina laser portfolio, including the PASCAL, IQ 532, IQ 577, and OcuLight TX models. Iridex's Cyclo G6 laser and glaucoma probes were already on contract with EyeProGPO, and the addition of the retina devices further strengthens the partnership by expanding the value Iridex can offer across ophthalmology practices, surgery centers, and hospitals.

  • The partnership was announced on April 7, 2026.

The players

Iridex Corporation

A worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases.

EyeProGPO

An ophthalmology-focused group purchasing organization serving ophthalmology practices, ambulatory surgery centers, and hospitals across the United States.

Phil Meyer

The COO of EyeProGPO, LLC.

Patrick Mercer

The President and CEO of Iridex.

Got photos? Submit your photos here. ›

What they’re saying

“We are thrilled to partner with Iridex to bring their cutting-edge retina laser technology to our members. This partnership reflects our strong commitment to equipping our members with the latest advancements in eye care technology, enabling them to deliver the highest quality patient care.”

— Phil Meyer, COO of EyeProGPO, LLC

“We are excited to partner with EyeProGPO to extend broader access to Iridex retina laser technology across its growing network of ophthalmology practices, ASCs, and hospitals. The on-contract status reinforces the credibility of our technology and enables a more streamlined sales process for our team and customers. This partnership reflects our commitment to supporting physicians with reliable, clinically proven laser solutions while helping providers realize meaningful value through exclusive member pricing.”

— Patrick Mercer, President and CEO of Iridex

What’s next

The partnership is expected to immediately expand the availability of Iridex's retina laser portfolio to EyeProGPO's growing network of ophthalmology practices, surgery centers, and hospitals.

The takeaway

This partnership demonstrates Iridex's focus on supporting ophthalmology providers with advanced, clinically proven laser technologies while also helping them achieve operational efficiency and cost savings through EyeProGPO's group purchasing model. It reflects the continued collaboration between medical device innovators and provider networks to improve access to the latest advancements in eye care.